Synthetic Communications · 2020 · 20 citations · 15 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoverySynthetic Medicinal ChemistryHeterocycle SynthesisHeterocyclic ChemistryLead Compound DesignLigand-based DesignStructure-activity Relationship AnalysisMedicinal Chemistry ApplicationsMedicinal HeterocyclesQuinoline ChemistryQuinoline SynthesisQuinoxaline ChemistryQuinoxaline Synthesis
A series of “drug-like” compounds based on quinoxaline scaffold with arylsulfonyl hydrazinyl, arylformyl hydrazinyl or arylsulfonyl groups at C-2 and aryloxy groups at C-3, were synthesized in 4 or 5 steps involving cyclization, chlorination and coupling reactions. Cellular anti-proliferative activities of these quinoxaline derivatives in vitro were determined, which revealed that the inhibitory potency and selectivity of 6f was comparable to that of the positive control.
15
Alison M. Schram, Leena Gandhi, Monica Mita et al. · British Journal of Cancer · 2018 · 95 citations · Full text
Medicine, Oncology, Pharmacology +17
Cellular Metabolic Heterogeneity In Vivo Is Recapitulated in Tumor Organoids
Joe T. Sharick, Justin J. Jeffery, Mohammad Rezaul Karim et al. · Neoplasia · 2019 · 76 citations · Full text
Medicine, Cancer Biology, Oncology +17
Chun Han, Zhangjian Huang, Chao Zheng et al. · Journal of Medicinal Chemistry · 2013 · 75 citations · Full text